LncRNA SATB2-AS1 overexpression represses the development of hepatocellular carcinoma through regulating the miR-3678-3p/GRIM-19 axis

Table 2 Relationship between the SATB2-AS1 expression and HCC patients’ clinical features

Clinical parameters		Patients (n)	Expression of SATB2-AS1		P-value
Clinical parameters		Patients (n)	High-SATB2-AS1	Low-SATB2-AS1	P-value
Total		84	42	42
Age (years)	< 70	34	15	19	0.374
Age (years)	≥ 70	50	27	23	0.374
Gender	Male	45	25	20	0.274
Gender	Female	39	17	22	0.274
Tumor size (cm)	< 5	24	14	10	0.334
Tumor size (cm)	≥ 5	60	28	32	0.334
Serum AFP(ng/ml)	< 20	33	15	18	0.503
Serum AFP(ng/ml)	≥ 20	51	27	24	0.503
Cirrhosis of the liver	Yes	58	28	30	0.637
Cirrhosis of the liver	No	26	14	12	0.637
TNM stage	I-II	34	23	11	0.008*
TNM stage	III-IV	50	19	31	0.008*
Tumor recurrence	Yes	59	25	34	0.032*
Tumor recurrence	No	25	17	8	0.032*

ISSN: 1475-2867